Tramadol Hydrochloride And Acetaminophen Tablet
FDA Label NDC 53746-617

62 label sections · Submitted to the FDA by Amneal Pharmaceuticals Of New York Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Amneal Pharmaceuticals Of New York Llc for the product Tramadol Hydrochloride And Acetaminophen (NDC 53746-617). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding warning: serious and life-threatening risks from use of tramadol hydrochloride and acetaminophen tablets, 1 indications and usage, 2.1 important dosage and administration instructions, 2.2 patient access to an opioid overdose reversal agent for the emergency treatment of opioid overdose, 2.3 initial dosage, 2.4 dosage modification in patients with renal impairment, 2.5 safe reduction or discontinuation of tramadol hydrochloride and acetaminophen tablets, 3 dosage forms and strengths, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Label Section Quick Index

* Please review the disclaimer below.